Drug Limits Dangerous Reactions ... the life threatening reaction before epinephrine injections are ... Specialized T Cells May Trigger Severe Asthma Attacks in Older Men Oct.
Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the Company has initiated a Phase 2 study of barzolvolimab in atopic dermatitis (AD) and that the study is actively enrolling patients. AD ...
Approximately 120 patients will be randomly assigned on a 1:1:1 ratio to receive subcutaneous injections of barzolvolimab at either 150 or 300 mg or placebo ... The disease is generally associated ...